Join the Kesimpta group to help and get support from people like you.
Kesimpta News
New MS Drug Kesimpta May Help Keep Symptoms at Bay
THURSDAY, July 18, 2024 – A new monoclonal antibody treatment called Kesimpta (ofatumumab) appears to improve on an older drug in pushing multiple sclerosis (MS) into remission, a new trial shows....
Ofatumumab Effective for MS Across Racial, Ethnic Subgroups
WEDNESDAY, July 17, 2024 – For patients with relapsing multiple sclerosis (RMS), ofatumumab is more effective than teriflunomide across racial and ethnic subgroups, according to a study published...
FDA Approves Kesimpta (ofatumumab) Targeted B-cell Therapy for Patients with Relapsing Multiple Sclerosis
Basel, August 20, 2020 — Novartis today announced that the US Food and Drug Administration (FDA) has approved Kesimpta® (ofatumumab, formerly OMB157) as an injection for subcutaneous use for the trea...
Ask a question
To post your own question to this support group, sign in or create an account.